| Curtis Doberstein, MD | |
|
1 Davol Sq, Providence, RI 02903-4755 | |
| (401) 621-8700 | |
| (401) 621-8705 |
| Full Name | Curtis Doberstein |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 36 Years |
| Location | 1 Davol Sq, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831176445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD08879 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
In patients with pre-existing heart or lung disease, being exposed to high levels of traffic-related air pollutants is associated with reduced heart rate variability —a risk factor for sudden cardiac death, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.
› Verified 2 days ago
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396849782 PECOS PAC ID: 8921900044 Enrollment ID: O20050211000311 |
News Archive
In patients with pre-existing heart or lung disease, being exposed to high levels of traffic-related air pollutants is associated with reduced heart rate variability —a risk factor for sudden cardiac death, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.
› Verified 2 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
In patients with pre-existing heart or lung disease, being exposed to high levels of traffic-related air pollutants is associated with reduced heart rate variability —a risk factor for sudden cardiac death, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Curtis Doberstein, MD 1 Davol Sq, Providence, RI 02903-4755 Ph: (401) 621-8700 | Curtis Doberstein, MD 1 Davol Sq, Providence, RI 02903-4755 Ph: (401) 621-8700 |
News Archive
In patients with pre-existing heart or lung disease, being exposed to high levels of traffic-related air pollutants is associated with reduced heart rate variability —a risk factor for sudden cardiac death, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.
A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.
› Verified 2 days ago
Dr. Elias Shaaya, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-793-9135 | |
Dr. Ki-eun Chang, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy Street Apc 6, Providence, RI 02903 Phone: 401-793-9166 Fax: 401-444-2788 | |
Dr. Belinda Shao, MD, MPH Neurological Surgery Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-793-9135 Fax: 401-444-2788 | |
Dr. Petra Margarete Klinge, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Claverick Street, Providence, RI 02903 Phone: 401-455-1749 Fax: 401-455-1292 | |
Sohail Syed, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 6, Providence, RI 02903 Phone: 401-444-4146 Fax: 401-444-2781 | |
Albert Edward Telfeian, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 6, Providence, RI 02903 Phone: 401-793-9153 Fax: 401-444-2024 | |
Dr. Beverly Claire Walters, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 128 N Main St, Providence, RI 02903 Phone: 401-351-1369 Fax: 401-251-0079 |